Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity

for
Mobile Applications, Cancer Patients
Location: The Bronx NY
Sponsor: Montefiore Medical Center

Sex: All

Age: 18+

Code: NCT06860425

Recruiting

Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer

for
Metastatic Cancer
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18+

Code: NCT07197671

Phase 1, Recruiting

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

for
Breast Cancer
Location: East Brunswick NJ, Jacksonville FL, Kansas City MO,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07368998

Phase 2, Recruiting

L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07220447

Early Phase 1, Recruiting

Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery

for
Breast Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05766891

Phase 2, Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: New Haven CT, Lake Success NY, Grand Rapids MI
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT07387068

Phase 1, Recruiting

Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study

for
Breast Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: Female

Age: 70+

Code: NCT07123649

Phase 2, Recruiting

A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, New Haven CT, Baltimore MD, Birmingham AL,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07226349

Phase 1, Recruiting

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

for
Neoplasms, Neoplasm Metastasis, Non-Small-Cell Lung Cancer
Location: Boston MA, Canton OH, Detroit MI
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.

Sex: All

Age: 18+

Code: NCT03797391

Phase 1, Phase 2, Recruiting

Positron Emission Tomography (PET) Imaging of Thrombosis

for
Atrial Fibrillation, COVID-19, Cancer, Thrombosis
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 70+

Code: NCT03830320

Phase 1, Recruiting

Prevent Cancer- Greenville

for
Cancer, High-Risk Cancer
Location: Greenville SC
Sponsor: Prisma Health-Upstate

Sex: All

Age: 18+

Code: NCT04947098

Recruiting

Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers

for
Metastatic Breast Cancer, Metastatic Prostate Cancer
Location: Ottawa, Kitchener
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT07252726

Recruiting

Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients

for
Breast Cancer, Adjuvant Treatment, Early Stage Breast Cancer
Location: Lebanon NH
Sponsor: Dartmouth-Hitchcock Medical Center

Sex: All

Age: 18+

Code: NCT07071038

Phase 2, Recruiting

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

for
Refractory Solid Tumor, Hepatocellular Carcinoma,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 30

Code: NCT05468359

Phase 1, Phase 2, Recruiting

SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers

for
Breast Cancer
Location: Boston MA
Sponsor: Beth Israel Deaconess Medical Center

Sex: All

Age: 18+

Code: NCT06896474

Recruiting

Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers

for
Advanced Malignant Solid Neoplasm,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05691517

Phase 1, Recruiting

A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment

for
IDH1-Mutated Malignancies
Location: Atlanta GA, Houston TX
Sponsor: Servier Bio-Innovation LLC

Sex: All

Age: 18+

Code: NCT07006688

Phase 1, Recruiting

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

for
Chemotherapy-Induced Peripheral Neuropathy,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT07365007

Recruiting

Thoracic Paravertebral Block Anesthesia for Breast Cancer Surgery

for
Breast Neoplasms, Breast Neoplasm Female, Cancer, Breast,
Location: Montreal
Sponsor: Ciusss de L'Est de l'Île de Montréal

Sex: Female

Age: 18+

Code: NCT05711030

Recruiting

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

for
Carcinomas (Including Squamous Cell and Adenocarcinoma),
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT00349830

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial